|Dr. John F. Regan||Founder, Chairman & CEO||200k||N/A||N/A|
|Mr. Darrel M. Rebeck||Pres & Director||157k||N/A||N/A|
|Mr. Jeffrey Mitchell||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Allan Fabbro||VP of Corp. Devel.||N/A||N/A||N/A|
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated pathogen detection platform in the life sciences and diagnostics industries. The company's platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. Its technology aims to transform the way organizations prevent and diagnose disease in various markets, such as food safety, veterinary diagnostics, water quality monitoring, aquaculture pathogen surveillance, and more. The company is headquartered in Beverly, Massachusetts.
LexaGene Holdings Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.